S. 5271, also known as the “BUPE for Recovery Act,” proposes that the Drug Enforcement Administration (DEA) exempt buprenorphine—a medication used for opioid addiction treatment—from being flagged in the Suspicious Orders Report System during the ongoing opioid public health...
Simple Explanation
S. 5271 wants to make it easier for people to get special medicine called buprenorphine, which helps people stop taking harmful drugs, by removing some red tape rules for a while. This will be tested to see if it helps more people get the medicine they need.